Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Global Urokinase (CAS 9039-53-6) main manufactuers include Syner-Med, LIVZON, Wanhua Biochem and Techpool, totally accounting for about 50% of the market. China is the largest market of Urokinase (CAS 9039-53-6), holding a share about 56%. As for the types of products, it can be divided into urokinase powder and urokinase polution. The most common type is urokinase powder, with a share about 92%. As for the applications of products, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share about 78%.
The global Urokinase market was valued at US$ 42 million in 2020 and is expected to reach US$ 61 million by the end of 2029, growing at a CAGR of 5.2% during 2021-2029.
This report focuses on Urokinase volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Urokinase market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Urokinase Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Urokinase Powder
Urokinase Solution
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
1 Urokinase Market Overview
1.1 Product Overview and Scope of Urokinase
1.2 Urokinase Segment by Type
1.2.1 Global Urokinase Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Urokinase Segment by Application
1.3.1 Global Urokinase Sales Comparison by Application: (2021-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Urokinase Market Size Estimates and Forecasts
1.4.1 Global Urokinase Revenue 2016-2029
1.4.2 Global Urokinase Sales 2016-2029
1.4.3 Urokinase Market Size by Region: 2016 Versus 2021 Versus 2029
2 Urokinase Market Competition by Manufacturers
2.1 Global Urokinase Sales Market Share by Manufacturers (2016-2021)
2.2 Global Urokinase Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Urokinase Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Urokinase Manufacturing Sites, Area Served, Product Type
2.5 Urokinase Market Competitive Situation and Trends
2.5.1 Urokinase Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Urokinase Players Market Share by Revenue
2.5.3 Global Urokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Urokinase Retrospective Market Scenario by Region
3.1 Global Urokinase Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Urokinase Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Urokinase Market Facts & Figures by Country
3.3.1 North America Urokinase Sales by Country
3.3.2 North America Urokinase Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Urokinase Market Facts & Figures by Country
3.4.1 Europe Urokinase Sales by Country
3.4.2 Europe Urokinase Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Urokinase Market Facts & Figures by Region
3.5.1 Asia Pacific Urokinase Sales by Region
3.5.2 Asia Pacific Urokinase Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Urokinase Market Facts & Figures by Country
3.6.1 Latin America Urokinase Sales by Country
3.6.2 Latin America Urokinase Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Urokinase Market Facts & Figures by Country
3.7.1 Middle East and Africa Urokinase Sales by Country
3.7.2 Middle East and Africa Urokinase Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Urokinase Historic Market Analysis by Type
4.1 Global Urokinase Sales Market Share by Type (2016-2021)
4.2 Global Urokinase Revenue Market Share by Type (2016-2021)
4.3 Global Urokinase Price by Type (2016-2021)
5 Global Urokinase Historic Market Analysis by Application
5.1 Global Urokinase Sales Market Share by Application (2016-2021)
5.2 Global Urokinase Revenue Market Share by Application (2016-2021)
5.3 Global Urokinase Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Syner-Med
6.1.1 Syner-Med Corporation Information
6.1.2 Syner-Med Description and Business Overview
6.1.3 Syner-Med Urokinase Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Syner-Med Urokinase Product Portfolio
6.1.5 Syner-Med Recent Developments/Updates
6.2 Wanhua Biochem
6.2.1 Wanhua Biochem Corporation Information
6.2.2 Wanhua Biochem Description and Business Overview
6.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Wanhua Biochem Urokinase Product Portfolio
6.2.5 Wanhua Biochem Recent Developments/Updates
6.3 Jiangxi Haoran Bio-Pharma
6.3.1 Jiangxi Haoran Bio-Pharma Corporation Information
6.3.2 Jiangxi Haoran Bio-Pharma Description and Business Overview
6.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio
6.3.5 Jiangxi Haoran Bio-Pharma Recent Developments/Updates
6.4 Jiangsu Aidea Pharmaceutical
6.4.1 Jiangsu Aidea Pharmaceutical Corporation Information
6.4.2 Jiangsu Aidea Pharmaceutical Description and Business Overview
6.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio
6.4.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates
6.5 Techpool
6.5.1 Techpool Corporation Information
6.5.2 Techpool Description and Business Overview
6.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Techpool Urokinase Product Portfolio
6.5.5 Techpool Recent Developments/Updates
6.6 Microbic Biosystems
6.6.1 Microbic Biosystems Corporation Information
6.6.2 Microbic Biosystems Description and Business Overview
6.6.3 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Microbic Biosystems Urokinase Product Portfolio
6.6.5 Microbic Biosystems Recent Developments/Updates
6.7 LIVZON
6.6.1 LIVZON Corporation Information
6.6.2 LIVZON Description and Business Overview
6.6.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2016-2021)
6.4.4 LIVZON Urokinase Product Portfolio
6.7.5 LIVZON Recent Developments/Updates
7 Urokinase Manufacturing Cost Analysis
7.1 Urokinase Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Urokinase
7.4 Urokinase Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Urokinase Distributors List
8.3 Urokinase Customers
9 Urokinase Market Dynamics
9.1 Urokinase Industry Trends
9.2 Urokinase Growth Drivers
9.3 Urokinase Market Challenges
9.4 Urokinase Market Restraints
10 Global Market Forecast
10.1 Urokinase Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Urokinase by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Urokinase by Type (2022-2029)
10.2 Urokinase Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Urokinase by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Urokinase by Application (2022-2029)
10.3 Urokinase Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Urokinase by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Urokinase by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Urokinase Sales (BIU) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Urokinase Sales (BIU) Comparison by Application (2021-2029)
Table 3. Global Urokinase Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Urokinase Covered in This Study
Table 5. Global Urokinase Sales (BIU) of Key Manufacturers (2016-2021)
Table 6. Global Urokinase Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Urokinase Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Urokinase Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Urokinase Average Price (US$/MIU) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Urokinase Manufacturing Sites and Area Served
Table 11. Manufacturers Urokinase Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Urokinase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urokinase as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Urokinase Sales by Region (2016-2021) & (BIU)
Table 16. Global Urokinase Sales Market Share by Region (2016-2021)
Table 17. Global Urokinase Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Urokinase Sales by Country (2016-2021) & (BIU)
Table 19. North America Urokinase Sales Market Share by Country (2016-2021)
Table 20. North America Urokinase Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Urokinase Revenue Market Share by Country (2016-2021)
Table 22. Europe Urokinase Sales by Country (2016-2021) & (BIU)
Table 23. Europe Urokinase Sales Market Share by Country (2016-2021)
Table 24. Europe Urokinase Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Urokinase Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Urokinase Sales by Region (2016-2021) & (BIU)
Table 27. Asia Pacific Urokinase Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Urokinase Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Urokinase Revenue Market Share by Region (2016-2021)
Table 30. Latin America Urokinase Sales by Country (2016-2021) & (BIU)
Table 31. Latin America Urokinase Sales Market Share by Country (2016-2021)
Table 32. Latin America Urokinase Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Urokinase Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Urokinase Sales by Country (2016-2021) & (BIU)
Table 35. Middle East and Africa Urokinase Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Urokinase Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Urokinase Revenue Market Share by Country (2016-2021)
Table 38. Global Urokinase Sales (BIU) by Type (2016-2021)
Table 39. Global Urokinase Sales Market Share by Type (2016-2021)
Table 40. Global Urokinase Revenue (Million US$) by Type (2016-2021)
Table 41. Global Urokinase Revenue Share by Type (2016-2021)
Table 42. Global Urokinase Price (US$/MIU) by Type (2016-2021)
Table 43. Global Urokinase Sales (BIU) by Application (2016-2021)
Table 44. Global Urokinase Sales Market Share by Application (2016-2021)
Table 45. Global Urokinase Revenue (Million US$) by Application (2016-2021)
Table 46. Global Urokinase Revenue Share by Application (2016-2021)
Table 47. Global Urokinase Price (US$/MIU) by Application (2016-2021)
Table 48. Syner-Med Corporation Information
Table 49. Syner-Med Description and Business Overview
Table 50. Syner-Med Urokinase Sales (BIU), Revenue (Million US$), Price (US$/MIU) and Gross Margin (2016-2021)
Table 51. Syner-Med Urokinase Product
Table 52. Syner-Med Recent Developments/Updates
Table 53. Wanhua Biochem Corporation Information
Table 54. Wanhua Biochem Description and Business Overview
Table 55. Wanhua Biochem Urokinase Sales (BIU), Revenue (Million US$), Price (US$/MIU) and Gross Margin (2016-2021)
Table 56. Wanhua Biochem Urokinase Product
Table 57. Wanhua Biochem Recent Developments/Updates
Table 58. Jiangxi Haoran Bio-Pharma Corporation Information
Table 59. Jiangxi Haoran Bio-Pharma Description and Business Overview
Table 60. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (Million US$), Price (US$/MIU) and Gross Margin (2016-2021)
Table 61. Jiangxi Haoran Bio-Pharma Urokinase Product
Table 62. Jiangxi Haoran Bio-Pharma Recent Developments/Updates
Table 63. Jiangsu Aidea Pharmaceutical Corporation Information
Table 64. Jiangsu Aidea Pharmaceutical Description and Business Overview
Table 65. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (Million US$), Price (US$/MIU) and Gross Margin (2016-2021)
Table 66. Jiangsu Aidea Pharmaceutical Urokinase Product
Table 67. Jiangsu Aidea Pharmaceutical Recent Developments/Updates
Table 68. Techpool Corporation Information
Table 69. Techpool Description and Business Overview
Table 70. Techpool Urokinase Sales (BIU), Revenue (Million US$), Price (US$/MIU) and Gross Margin (2016-2021)
Table 71. Techpool Urokinase Product
Table 72. Techpool Recent Developments/Updates
Table 73. Microbic Biosystems Corporation Information
Table 74. Microbic Biosystems Description and Business Overview
Table 75. Microbic Biosystems Urokinase Sales (BIU), Revenue (Million US$), Price (US$/MIU) and Gross Margin (2016-2021)
Table 76. Microbic Biosystems Urokinase Product
Table 77. Microbic Biosystems Recent Developments/Updates
Table 78. LIVZON Corporation Information
Table 79. LIVZON Description and Business Overview
Table 80. LIVZON Urokinase Sales (BIU), Revenue (Million US$), Price (US$/MIU) and Gross Margin (2016-2021)
Table 81. LIVZON Urokinase Product
Table 82. LIVZON Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Urokinase Distributors List
Table 86. Urokinase Customers List
Table 87. Urokinase Market Trends
Table 88. Urokinase Growth Drivers
Table 89. Urokinase Market Challenges
Table 90. Urokinase Market Restraints
Table 91. Global Urokinase Sales Forecast by Type (2022-2029) & (BIU)
Table 92. Global Urokinase Sales Market Share Forecast by Type (2022-2029)
Table 93. Global Urokinase Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 94. Global Urokinase Revenue Market Share Forecast by Type (2022-2029)
Table 95. Global Urokinase Sales Forecast by Application (2022-2029) & (BIU)
Table 96. Global Urokinase Sales Market Share Forecast by Application (2022-2029)
Table 97. Global Urokinase Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 98. Global Urokinase Revenue Market Share Forecast by Application (2022-2029)
Table 99. Global Urokinase Sales Forecast by Region (2022-2029) & (BIU)
Table 100. Global Urokinase Sales Market Share Forecast by Region (2022-2029)
Table 101. Global Urokinase Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 102. Global Urokinase Revenue Market Share Forecast by Region (2022-2029)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Urokinase
Figure 2. Global Urokinase Market Share by Type in 2020 & 2029
Figure 3. Urokinase Powder Product Picture
Figure 4. Urokinase Solution Product Picture
Figure 5. Global Urokinase Market Share by Application in 2020 & 2029
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Urokinase Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 10. Global Urokinase Market Size 2016-2029 (US$ Million)
Figure 11. Global Urokinase Sales 2016-2029 (BIU)
Figure 12. Global Urokinase Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 13. Urokinase Sales Share by Manufacturers in 2020
Figure 14. Global Urokinase Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Urokinase Players: Market Share by Revenue in 2020
Figure 16. Urokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Urokinase Sales Market Share by Region (2016-2021)
Figure 18. Global Urokinase Sales Market Share by Region in 2020
Figure 19. Global Urokinase Revenue Market Share by Region (2016-2021)
Figure 20. Global Urokinase Revenue Market Share by Region in 2020
Figure 21. United States Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Urokinase Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Urokinase by Type (2016-2021)
Figure 44. Sales Market Share of Urokinase by Application (2016-2021)
Figure 45. Sales Market Share of Urokinase by Application in 2020
Figure 46. Revenue Share of Urokinase by Application (2016-2021)
Figure 47. Revenue Share of Urokinase by Application in 2020
Figure 48. Manufacturing Cost Structure of Urokinase
Figure 49. Manufacturing Process Analysis of Urokinase
Figure 50. Urokinase Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
